Compound ID | 2112
Synonym(s): EN-7 | SU-3327 | SU3327
Class: Thiadiazole
Spectrum of activity: | Gram-positive & Gram-negative |
Details of activity: | Disrupts the maintainance of an electrochemical gradient across the membrane. Activity against E. coli, Acinetobacter and Mycobacterium tuberculosis |
Description: | Synthetic compound; repurposed c-Jun N-terminal kinase inhibitor SU3327 (diabetic treatment) through machine learning modeling and experimental design. |
Year first mentioned: | 2019 |
Development status: | Experimental |
Chemical structure(s): | |
Canonical SMILES: | C1=C([N+](=O)[O-])SC(=N1)SC2=NN=C(N)S2 |
Isomeric SMILES: | C1=C(SC(=N1)SC2=NN=C(S2)N)[N+](=O)[O-] |
InChI: | InChI=1S/C5H3N5O2S3/c6-3-8-9-5(14-3)15-4-7-1-2(13-4)10(11)12/h1H,(H2,6,8) |
InChI Key: | NQQBNZBOOHHVQP-UHFFFAOYSA-N |
Structure link: | https://pubchem.ncbi.nlm.nih.gov/compound/11837140 |